Question 1

What are delayed-release oral drug delivery systems and why are they used?

Accepted Answer

Delayed-release systems are modified-release formulations that postpone drug release until the medication reaches a specific site in the gastrointestinal tract, typically the intestine. They address challenges like gastric irritation and acid-induced drug degradation while enabling localized therapeutic action. These systems are particularly valuable for drugs that cause stomach damage or are unstable in acidic environments.

Question 2

How do enteric coatings control drug release in delayed-release systems?

Accepted Answer

Enteric coatings use pH-sensitive polymers like cellulose acetate phthalate or methacrylic acid copolymers to prevent drug dissolution in the stomach's low pH (1–3) and enable release in the higher intestinal pH (5–7.5). The drug remains intact while passing through the stomach and begins dissolving only upon reaching the intestine, minimizing gastric side effects and enhancing therapeutic efficacy.

Question 3

What are common examples of delayed-release drug formulations?

Accepted Answer

Enteric-coated aspirin and diclofenac are common examples of delayed-release formulations used to reduce gastrointestinal irritation caused by nonsteroidal anti-inflammatory drugs. Mesalamine represents a specialized targeted-release system designed to release medication in the terminal ileum and colon for treating inflammatory bowel diseases like ulcerative colitis and Crohn's disease.

Question 4

How do delayed-release systems differ from targeted-release systems?

Accepted Answer

Delayed-release systems postpone drug release until reaching the intestine using pH-sensitive coatings, while targeted-release systems like mesalamine employ additional mechanisms such as time-dependent release or biodegradable polymers activated by colonic bacteria to achieve precise drug localization at specific intestinal sites for enhanced therapeutic outcomes.

Question 5

Why are delayed-release systems important for NSAID formulations?

Accepted Answer

Nonsteroidal anti-inflammatory drugs like aspirin and diclofenac can cause gastric mucosal damage when released in the stomach. Delayed-release formulations reduce gastrointestinal irritation by delaying drug release until the medication reaches the intestine, protecting the stomach lining while maintaining therapeutic efficacy and minimizing systemic side effects.

Question 6

What polymers are used in enteric coatings for delayed-release systems?

Accepted Answer

Enteric coatings typically employ pH-sensitive polymers such as cellulose acetate phthalate and methacrylic acid copolymers. These materials provide site-specific protection by resisting dissolution in the acidic gastric environment and dissolving at higher intestinal pH levels, ensuring controlled drug release at the target site.

Question 7

How do colonic delivery systems work in delayed-release formulations?

Accepted Answer

Colonic delivery systems use biodegradable polymers activated by colonic bacteria to achieve precise drug localization in the colon. These formulations may combine time-dependent mechanisms with pH-sensitive coatings to ensure the drug reaches the target site intact, enabling effective treatment of colonic diseases while minimizing exposure to upper gastrointestinal tissues.

מערכות להובלת תרופות דרך הפה: מערכות שחרור מושהה

Browse More Videos